Dimitrios Agapakis

503 total citations
19 papers, 127 citations indexed

About

Dimitrios Agapakis is a scholar working on Epidemiology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dimitrios Agapakis has authored 19 papers receiving a total of 127 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dimitrios Agapakis's work include Lipoproteins and Cardiovascular Health (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Dimitrios Agapakis is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Dimitrios Agapakis collaborates with scholars based in Greece. Dimitrios Agapakis's co-authors include Apostolos Hatzitolios, Κωνσταντίνος Τζιόμαλος, Christos Savopoulos, George Ntaios, Eleni Massa, Antonis Goulas, Georgios Germanidis, Vaia Lambadiari, Eleni Mouloudi and Christina Antza and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Atherosclerosis.

In The Last Decade

Dimitrios Agapakis

17 papers receiving 126 citations

Peers

Dimitrios Agapakis
René C. Bakker Netherlands
Ivana Dedinská Slovakia
Maria Mouktaroudi Greece
Yves-Édouard Herpe France
И. И. Шапошник Russia
Stefano Rota Italy
Gordana Miloševski‐Lomić Serbia
И. А. Ефимова Russia
Habib Haouala Tunisia
René C. Bakker Netherlands
Dimitrios Agapakis
Citations per year, relative to Dimitrios Agapakis Dimitrios Agapakis (= 1×) peers René C. Bakker

Countries citing papers authored by Dimitrios Agapakis

Since Specialization
Citations

This map shows the geographic impact of Dimitrios Agapakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Agapakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Agapakis more than expected).

Fields of papers citing papers by Dimitrios Agapakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitrios Agapakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Agapakis. The network helps show where Dimitrios Agapakis may publish in the future.

Co-authorship network of co-authors of Dimitrios Agapakis

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios Agapakis. A scholar is included among the top collaborators of Dimitrios Agapakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios Agapakis. Dimitrios Agapakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Makri, Evangelia, et al.. (2023). An association study of the PNPLA3 I148M polymorphism (rs738409) with serum lipids in patients with dyslipidemia. SHILAP Revista de lepidopterología. 16–22. 2 indexed citations
4.
Rizos, Christos V., Ioannis Skoumas, Lοukianos S. Rallidis, et al.. (2021). LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments. International Journal of Cardiology. 345. 119–124. 16 indexed citations
5.
Anagnostis, Panagiotis, Christos V. Rizos, Ioannis Skoumas, et al.. (2021). Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH. Current Pharmaceutical Design. 27(21). 2537–2544. 2 indexed citations
6.
Rizos, Christos V., Ioannis Skoumas, Lοukianos S. Rallidis, et al.. (2021). Prevalence of non-coronary heart disease in patients with familial hypercholesterolemia: An analysis from the HELLAS-FH. Atherosclerosis. 331. e185–e186. 1 indexed citations
7.
Massa, Eleni, Dimitrios Agapakis, Stavros Papadopoulos, et al.. (2019). Colonization and Infection With Extensively Drug Resistant Gram-Negative Bacteria in Liver Transplant Recipients. Transplantation Proceedings. 51(2). 454–456. 17 indexed citations
8.
9.
Goulas, Antonis, et al.. (2016). Association of the Common Catalase Gene Polymorphism rs1001179 With Glycated Hemoglobin and Plasma Lipids in Hyperlipidemic Patients. Biochemical Genetics. 55(1). 77–86. 4 indexed citations
10.
Τζιόμαλος, Κωνσταντίνος, George Ntaios, Spiros Miyakis, et al.. (2016). Prophylactic antibiotic treatment in severe acute ischemic stroke: the Antimicrobial chemopRrophylaxis for Ischemic STrokE In MaceDonIa–Thrace Study (ARISTEIDIS). Internal and Emergency Medicine. 11(7). 953–958. 7 indexed citations
11.
Agapakis, Dimitrios, Christos Savopoulos, Kyriakos E. Kypreos, et al.. (2016). Association of the CETP Taq1B and LIPG Thr111Ile Polymorphisms with Glycated Hemoglobin and Blood Lipids in Newly Diagnosed Hyperlipidemic Patients. Canadian Journal of Diabetes. 40(6). 515–520. 4 indexed citations
12.
Goulas, Antonis, Vassilios Sevastianos, Stephanos J. Hadziyannis, et al.. (2015). Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population. Pharmacological Reports. 68(2). 476–482. 6 indexed citations
13.
Agapakis, Dimitrios, et al.. (2010). Coagulation and inflammation biomarkers may help predict the severity of community‐acquired pneumonia. Respirology. 15(5). 796–803. 29 indexed citations
14.
Agapakis, Dimitrios, et al.. (2010). MS9 EFFECTIVENESS OF OMACOR MONOTHERAPY IN SEVERE HYPERTRIGLYCERIDEMIA. Atherosclerosis Supplements. 11(2). 110–111. 1 indexed citations
15.
16.
Ntaios, George, et al.. (2009). Trend in incidence of cardiovascular risk factors in elderly and over-aged stroke patients between 2003 and 2007 in Greece. Archives of Gerontology and Geriatrics. 50(3). e31–e35. 13 indexed citations
17.
Ntaios, George, Anastasia Chatzinikolaou, Georgia Kaiafa, et al.. (2007). Discrimination Indices as Screening Tests for Beta-Thalassemic Trait.. Blood. 110(11). 3815–3815. 9 indexed citations
18.
Agapakis, Dimitrios, et al.. (2006). Tu-P10:401 Hyperhomocysteinemia as a risk factor for stroke. Atherosclerosis Supplements. 7(3). 272–272. 1 indexed citations
19.
Agapakis, Dimitrios, et al.. (2001). [Adamantiadi-Behçet syndrome: treatment with recombinant leukocytic interferon].. PubMed. 73(5). 43–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by René C. Bakker Breakdown of academic impact, for papers by Ivana Dedinská Breakdown of academic impact, for papers by Maria Mouktaroudi Breakdown of academic impact, for papers by Yves-Édouard Herpe Breakdown of academic impact, for papers by И. И. Шапошник Breakdown of academic impact, for papers by Stefano Rota Breakdown of academic impact, for papers by Gordana Miloševski‐Lomić Breakdown of academic impact, for papers by И. А. Ефимова Breakdown of academic impact, for papers by Habib Haouala
Rankless by CCL
2026